{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T17:24:06Z","timestamp":1794677046333,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020448","name":"Korean Society for the Study of Obesity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["20013712"],"award-info":[{"award-number":["20013712"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["E0210601-02"],"award-info":[{"award-number":["E0210601-02"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003712","name":"Korea Food Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.metabol.2024.155789","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T22:06:49Z","timestamp":1705183609000},"page":"155789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study"],"prefix":"10.1016","volume":"152","author":[{"given":"Eugene","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Wan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Seok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Soo","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.155789_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4093\/dmj.2022.0444","article-title":"Fatty liver & diabetes statistics in Korea: nationwide data 2009 to 2017","volume":"47","author":"Han","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2024.155789_bb0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"2138\u201347","key":"10.1016\/j.metabol.2024.155789_bb0020","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0025","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/jgh.16261","article-title":"MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: a nationwide study","volume":"38","author":"Han","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0030","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0035","doi-asserted-by":"crossref","first-page":"786","DOI":"10.5009\/gnl210290","article-title":"Fibrotic burden determines cardiovascular risk among subjects with metabolic dysfunction-associated fatty liver disease","volume":"16","author":"Han","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.metabol.2024.155789_bb0040","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3350\/cmh.2022.0070","article-title":"Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: prevalence, outcomes and implications of a change in name","volume":"28","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3350\/cmh.2021.0310","article-title":"MAFLD enhances clinical practice for liver disease in the Asia-Pacific region","volume":"28","author":"Kawaguchi","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ije\/dyt228","article-title":"Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)","volume":"43","author":"Kweon","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2024.155789_bb0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155789_bb0065","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2024.155789_bb0070","first-page":"9","article-title":"Comparative assessment and external validation of hepatic steatosis formulae in a community-based setting","author":"Jung","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2024.155789_bb0075","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"European Association for the Study of the Liver. Electronic address eee, Clinical Practice Guideline P, Chair, representative EGB, Panel m","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.29568","article-title":"Diagnostic performance of the Fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score in lean adults with nonalcoholic fatty liver disease","volume":"6","author":"Park","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.metabol.2024.155789_bb0085","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00535-018-1474-y","article-title":"The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study","volume":"53","author":"Ishiba","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.metabol.2024.155789_bb0090","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of O. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the L, European Association for the Study of D","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0095","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155789_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4093\/dmj.2023.0282","article-title":"2023 clinical practice guidelines for diabetes mellitus of the Korean Diabetes Association","volume":"47","author":"Choi","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2024.155789_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of obesity","volume":"32","author":"Haam","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.metabol.2024.155789_bb0110","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2024.155789_bb0115","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4093\/dmj.2021.0327","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality: a population-based cohort study","volume":"47","author":"Kim","year":"2023","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2024.155789_bb0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.32131","article-title":"Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: the Rotterdam Study","volume":"75","author":"van Kleef","year":"2022","journal-title":"Hepatology"},{"issue":"1625\u201333","key":"10.1016\/j.metabol.2024.155789_bb0130","article-title":"Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/hep.30864","article-title":"Risks of light and moderate alcohol use in fatty liver disease: follow-up of population cohorts","volume":"71","author":"Aberg","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155789_bb0140","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3350\/cmh.2020.0163","article-title":"The effect of moderate alcohol drinking in nonalcoholic fatty liver disease","volume":"26","author":"Choi","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0145","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"2172\u201381","key":"10.1016\/j.metabol.2024.155789_bb0150","article-title":"Differential clinical characteristics and mortality outcomes in persons with NAFLD and\/or MAFLD","volume":"19","author":"Nguyen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1041\u20139","key":"10.1016\/j.metabol.2024.155789_bb0155","article-title":"Nomenclature dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): considerable proportions of MAFLD are metabolic healthy","volume":"21","author":"Park","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3350\/cmh.2022.0096","article-title":"The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease","volume":"28","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.metabol.2024.155789_bb0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4093\/dmj.2020.0039","article-title":"Distinct dose-dependent association of free fatty acids with diabetes development in nonalcoholic fatty liver disease patients","volume":"45","author":"Li","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metabol.2024.155789_bb0170","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.155789_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic fatty liver disease","volume":"31","author":"Huh","year":"2022","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.metabol.2024.155789_bb0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12916-014-0154-x","article-title":"Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA","volume":"12","author":"Cheung","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.metabol.2024.155789_bb0185","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2024.155789_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4093\/dmj.2019.0011","article-title":"Nonalcoholic fatty liver disease in diabetes. Part I: epidemiology and diagnosis","volume":"43","author":"Lee","year":"2019","journal-title":"Diabetes Metab J"}],"updated-by":[{"DOI":"10.1016\/j.metabol.2024.155819","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000}}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524000155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524000155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:36:59Z","timestamp":1758429419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524000155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":38,"alternative-id":["S0026049524000155"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155789","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155789"}}